Evidence map›Paper›PMID 38238697›Full record

ArticleBMC health services research2024

A mixed methods evaluation assessing the feasibility of implementing a PrEP data dashboard in the Southeastern United States.

Kaylee Burgan, C Greer McCollum, Alfredo Guzman, Brooke Penney, Samantha V Hill, Kachina Kudroff, Shey Thorn, Toya Burton, Kelly Turner, Michael J Mugavero and 2 more

Abstract read
In one paragraph

Article in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Building Public Health Data Dashboards: Tutorial Playbook.JMIR public health and surveillance · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kaylee BurganDivision of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA.
C Greer McCollumDivision of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA.
Alfredo GuzmanDivision of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA.
Brooke PenneyDivision of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA.
Samantha V HillDepartment of Pediatrics, Division of Adolescent Medicine, University of Alabama at Birmingham, Birmingham, USA.
Kachina KudroffDivision of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA.
Shey ThornFive Horizons Health Services, Montgomery, AL, 36111, USA.
Toya BurtonWhatley Health Services, Tuscaloosa, AL, 35401, USA.
Kelly TurnerHealth Services Center, Hobson City, AL, 36201, USA.
Michael J MugaveroDivision of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA.
Aadia RanaDivision of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA.
Latesha ElopreDivision of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, USA. lelopre@uabmc.edu.

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Latesha Ellen Elopre · 1988 to 2026
$84.1M
NIAID NIH HHS P30 AI027767
6 · The paper itself

Abstract

backgroundAlabama is one of seven priority states for the National Ending the HIV Epidemic Initiative due to a disproportionate burden of rural infections. To reverse growing infection rates, the state must increase its focus on prevention efforts, including novel strategies. One such approach is to utilize dashboards that visualize real-time data on the pre-exposure prophylaxis (PrEP) care continuum to assist in prioritizing evidence-based preventative care for those most vulnerable for HIV infection.

methodsWe conducted a mixed methods evaluation to ascertain stakeholders' perceptions on the acceptability, feasibility, appropriateness, and usability of a PrEP care continuum dashboard, as well as gain insight on ways to improve the activities necessary to sustain it. Clinicians, administrators, and data personnel from participating sites in Alabama completed surveys (n = 9) and participated in key informant interviews (n = 10) to better understand their experiences with the prototype data dashboard and to share feedback on how it can be modified to best fit their needs.

resultsSurveys and interviews revealed that all participants find the pilot data dashboard to be an acceptable, feasible, and appropriate intervention for clinic use. Overall, stakeholders find the pilot dashboard to be usable and helpful in administrative efforts, such as report and grant writing; however, additional refining is needed in order to reduce burden and optimize usefulness. Participants voiced concerns about their site's abilities to sustain the dashboard, including the lack of systematized PrEP protocols and limited funds and staff time dedicated to PrEP data collection, cleaning, and upload.

conclusionStudy participants from clinics providing HIV prevention services, including PrEP, in Alabama voiced interest in sustaining and refining a data dashboard that tracks clients across the PrEP care continuum. Despite viewing the platform itself as an acceptable, feasible, and appropriate intervention, participants agreed that efforts need to be focused on standardizing PrEP data collection protocols in order to ensure consistent, accurate data capture and that limited funds and staff time are barriers to the sustained implementation of the dashboard in practice.

Indexed as

Acquired Immunodeficiency SyndromeAnti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisFeasibility StudiesHumansSoutheastern United StatesAnti-HIV AgentsCare continuumData dashboardPre-exposure prophylaxisPrEP

Identifiers

PMID38238697
PMCPMC10797978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.